Condensed Consolidated Interim Balance Sheets - USD ($)	Jun. 30, 2025	Mar. 31, 2025
CURRENT ASSETS
Cash	$ 391,292	$ 365,145
Accounts receivable, net	1,860,715	1,658,772
Inventory [Note 3]	1,783,426	1,555,385
Deposits and other receivables	1,109,107	1,059,990
Total current assets	5,144,540	4,639,292
Deposits and other receivables [Note 10]	109,297	109,297
Long-term accounts receivable	74,188	70,713
Property and equipment [Note 12]	8,111	9,599
Operating right of use assets [Note 10]	701,183	812,053
TOTAL ASSETS	6,037,319	5,640,954
CURRENT LIABILITIES
Accounts payable and accrued liabilities [Note 4]	7,856,775	7,661,924
Convertible promissory notes and short term loans [Note 5]	10,084,601	9,618,738
Term loan, current	2,400,000	2,400,000
Derivative liabilities [Note 8]	438,162	424,200
Advance from customers	475,575
Operating lease obligations, current [Note 10]	551,208	531,286
Total current liabilities	21,806,321	20,636,148
Federally guaranteed loans [Note 7]	870,800	870,800
Term loan [Note 6]	12,425,131	12,271,559
Derivative liabilities [Note 8]	1,481,522	1,478,717
Operating lease obligations	252,172	397,830
TOTAL LIABILITIES	36,835,946	35,655,054
STOCKHOLDERS’ DEFICIENCY
Preferred stock, $0.001 and $0.001 par value, 9,979,400 and 9,979,400 shares authorized as of June 30, 2025 and March 31, 2025, respectively, 1 and 1 share issued and outstanding as of June 30, 2025 and March 31, 2025 [Note 9]	1	1
Common stock, $0.001 and $0.001 par value, 125,000,000 and 125,000,000 shares authorized as at June 30, 2025 and March 31, 2025, respectively. Issued and outstanding common shares: 26,567,769 and 26,081,295 as at June 30, 2025 and March 31, 2025, respectively, and exchangeable shares of 160,672 and 160,672 outstanding as at June 30, 2025 and March 31, 2025, respectively [Note 9]	26,729	26,243
Shares to be issued 581,599 and 581,599 shares of common stock as at June 30, 2025 and March 31, 2025, respectively) [Note 9]	284,244	284,244
Additional paid-in-capital	106,976,564	106,971,115
Accumulated other comprehensive income	109,623	145,792
Accumulated deficit	(140,196,078)	(139,441,785)
Total stockholders’ deficiency	(32,798,917)	(32,014,390)
TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ DEFICIENCY	6,037,319	5,640,954
Series B Convertible Redeemable Preferred Stock [Member]
MEZZANINE EQUITY
Series B Convertible Redeemable preferred stock, $0.001 and $0.001 par value, 600 and 600 shares authorized as of June 30, 2025 and March 31, 2025, respectively, 385 and 385 shares issued and outstanding as of June 30, 2025 and March 31, 2025, respectively [Note 9]	$ 2,000,290	$ 2,000,290